These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5983543)
61. [Diagnostic difficulties in pathological states of the genital tract in women with uterine devices. Report of our cases]. Ivanov I; Smilov I; Tarakchiev Khr Akush Ginekol (Sofiia); 1971; 10(5):391-4. PubMed ID: 5143523 [No Abstract] [Full Text] [Related]
62. [Electron microscopic changes in the endometrium caused by encrusted intrauterine contraceptives]. Patai K Zentralbl Gynakol; 1983; 105(18):1189-93. PubMed ID: 6637248 [TBL] [Abstract][Full Text] [Related]
63. [Study on the relationship between uterine bleeding with intrauterine device and viral infection]. Xu H; Tian X; Li F Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):414-6. PubMed ID: 7587578 [TBL] [Abstract][Full Text] [Related]
64. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen). Roy S; Shaw ST Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136 [TBL] [Abstract][Full Text] [Related]
65. The current status of intra-uterine contraceptive devices and systems. Newton J Br J Fam Plann; 2000 Jan; 26(1):14-5. PubMed ID: 10819587 [No Abstract] [Full Text] [Related]
66. [Cervicovaginal and endometrial cytology in women fitted with intrauterine devices]. Tanferna M; Panazzolo A; Amosso B; Fantoni A; Chiappa A Minerva Ginecol; 1984 Dec; 36(12):805-14. PubMed ID: 6533488 [No Abstract] [Full Text] [Related]
67. [Effectiveness, complications and failures of the Spiran-type intrauterine device]. Horoszko-Husiatyńska B; Peterek J Wiad Lek; 1980 Feb; 33(4):245-9. PubMed ID: 7395200 [No Abstract] [Full Text] [Related]
68. [Use of intrauterine devices from the oncologic viewpoint]. Michalica W Wien Med Wochenschr; 1974 Sep; 124(38):548-50. PubMed ID: 4411433 [No Abstract] [Full Text] [Related]
69. Use of statistical procedure to evaluate intrauterine contraception. Berúmen-Cortéz C; Ramírez-Alvarez J; García de Alba JE; Luna-Reyes RD Arch Invest Med (Mex); 1982; 13(3):195-211 passim. PubMed ID: 7125800 [No Abstract] [Full Text] [Related]
70. The concept of dysfunctional uterine bleeding with I.U.C.D. Mukherjee K; Dey U; Roy S; Sen P; Banerjee SK J Indian Med Assoc; 1967 Jul; 49(1):37-43. PubMed ID: 6074843 [No Abstract] [Full Text] [Related]
71. Antifibrinolytic control of menorrhagia after I.U.D. insertion. MacMath IF Practitioner; 1973 Mar; 210(257):417-20. PubMed ID: 4571360 [No Abstract] [Full Text] [Related]
72. Rare cause of vaginal bleeding in early puberty. Davis VJ; Dizon CD; Minuk CF J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):113-5. PubMed ID: 15897108 [TBL] [Abstract][Full Text] [Related]
73. Noncontraceptive applications of the levonorgestrel intrauterine system. Jensen JT Curr Womens Health Rep; 2002 Dec; 2(6):417-22. PubMed ID: 12429074 [TBL] [Abstract][Full Text] [Related]
74. Deposit on the surface of IUDs. A preliminary report. Tötterman LE; Arstila AA Ann Chir Gynaecol Fenn; 1971; 60(3):115-8. PubMed ID: 5156618 [No Abstract] [Full Text] [Related]
78. An appraisal of the use of an intra-uterine device in general practice. Tooley PJ Practitioner; 1972 Apr; 208(246):543-5. PubMed ID: 5031045 [No Abstract] [Full Text] [Related]
79. Intrauterine devices. Their role in family planning care. WHO Offset Publ; 1983; (75):1-53. PubMed ID: 6637075 [No Abstract] [Full Text] [Related]
80. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD). Dasgupta PR; Dutta S; Banerjee P; Majumdar S Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]